Similar antifibrotic effects were reported in non-small cell lung cancer [40], atrial fibrillation-induced myocardial fibrosis [14], and TGF-β1-induced peritoneal fibrosis [10]. This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.